Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-11-09FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for SEROQUEL (quetiapine) from H2-Pharma, LLC.
-
FDA approval · 2011-11-09FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA has approved a supplemental application for SEROQUEL XR (quetiapine) by AstraZeneca Pharmaceuticals LP. The approval pertains to mod…
-
FDA approval · 2011-08-19FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for SERTRALINE HYDROCHLORIDE (Mylan Pharmaceuticals Inc.), indicating regulatory action on this gene…
-
FDA approval · 2011-08-12FDA Approved: CELEXA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Celexa (citalopram) filed by Allergan, Inc.
-
FDA approval · 2011-08-08FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for bupropion hydrochloride from Aurobindo Pharma Limited, allowing the generic product to be market…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-07-27FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for paroxetine hydrochloride (paroxetine) from Zydus Lifesciences Limited under an ANDA.
-
FDA approval · 2011-07-26FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)
FDA approves a supplemental application for WELLBUTRIN XL (bupropion hydrochloride) from Bausch Health US LLC.
-
FDA approval · 2011-07-26FDA Approved: APLENZIN — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for APLENZIN (bupropion hydrobromide) from Bausch Health US, LLC. This action updates the product la…
-
FDA approval · 2011-07-08FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for SEROQUEL (quetiapine) submitted by H2-Pharma, LLC.
-
FDA approval · 2011-06-28FDA Approved: MIRTAZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for mirtazapine submitted by Mylan Pharmaceuticals Inc. under an ANDA. This action confirms approval…
-
FDA approval · 2011-06-28FDA Approved: MIRTAZAPINE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for mirtazapine (generic) under an ANDA.
-
FDA approval · 2011-06-06FDA Approved: MIRTAZAPINE — Supplemental Application (Aurolife Pharma LLC)
The FDA approved a supplemental application for mirtazapine from Aurolife Pharma LLC, updating the regulatory status of the generic product.
-
FDA approval · 2011-05-17FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SEROQUEL XR (quetiapine) by AstraZeneca Pharmaceuticals LP to update or expand the labeling.
-
FDA approval · 2011-05-12FDA Approved: LEXAPRO — Supplemental Application (Allergan, Inc.)
FDA has approved a supplemental application for Lexapro (escitalopram) submitted by Allergan, Inc.
-
FDA approval · 2011-05-06FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Dr.Reddys Laboratories Inc)
FDA approved the original ANDA for Venlafaxine hydrochloride by Dr. Reddy's Laboratories Inc, enabling a generic version of this antidepress…
-
FDA approval · 2011-04-29FDA Approved: APLENZIN — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for APLENZIN (bupropion hydrobromide) from Bausch Health US, LLC.
-
FDA approval · 2011-04-14FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original ANDA for venlafaxine hydrochloride from Zydus Pharmaceuticals USA Inc., authorizing a generic version of the antid…
-
FDA approval · 2011-04-14FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original ANDA for venlafaxine hydrochloride, a generic antidepressant.
-
FDA approval · 2011-04-12FDA Approved: CYMBALTA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Cymbalta (duloxetine hydrochloride) submitted by Eli Lilly and Company.
-
FDA approval · 2011-04-11FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved the extended-release formulation of Pristiq (desvenlafaxine succinate) under a supplemental application filed by Wyeth Phar…
-
FDA approval · 2011-03-14FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for sertraline hydrochloride from Aurobindo Pharma Limited, enabling its generic product.
-
FDA approval · 2011-03-04FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Pristiq Extended-Release (desvenlafaxine succinate) from Wyeth/Pfizer, confirming the approval o…
-
FDA approval · 2011-03-04FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for paroxetine hydrochloride from Zydus Lifesciences Limited.
-
FDA approval · 2011-03-02FDA Approved: ABILIFY — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
FDA approved a supplemental NDA for ABILIFY (aripiprazole) submitted by Otsuka America Pharmaceutical, Inc., to modify the product labeling …
-
FDA approval · 2011-01-31FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for Pristiq Extended-Release (desvenlafaxine succinate) from Wyeth Pharmaceuticals (a Pfizer sub…